SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001437749-23-031869
Filing Date
2023-11-14
Accepted
2023-11-14 13:12:27
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D inbp20230921_sc13d.htm SC 13D 88354
2 EXHIBIT 99.1 JOINT FILING AGREEMENT ex_596378.htm EX-99.1 6668
  Complete submission text file 0001437749-23-031869.txt   97018
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filed by) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Subject) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D | Act: 34 | File No.: 005-52311 | Film No.: 231403649
SIC: 2834 Pharmaceutical Preparations